Advertisement

Picture EBD Group BioPharm America 2019 Boston September 600x60px
Organisation › Details

Pieris Pharmaceuticals Inc. (Nasdaq: PIRS)

Pieris is a clinical-stage biotechnology company that discovers and develops Anticalin® protein-based drugs to target validated disease pathways in a unique and transformative way. Our pipeline includes immuno-oncology multi-specifics tailored for the tumor microenvironment, an inhaled Anticalin protein to treat uncontrolled asthma and a half-life-optimized Anticalin protein to treat anemia. Proprietary to Pieris, Anticalin proteins are a novel class of therapeutics validated in the clinic and by partnerships with leading pharmaceutical companies. *

 

Period Start 2014-12-17 merged
  Group Pieris (Group)
  Predecessor Marika Inc.
Products Industry BIOTECH
  Industry 2 Anticalin® scaffold technology
Persons Person Yoder, Stephen S. (Steve) (Pieris 201001– CEO before MorphoSys Head Licensing + IP)
  Person 2 Deptula-Hicks, Darlene (Pieris 201509–201702 CFO before consultant to Pieris RESIGNED 2/17)
     
Region Region Boston, MA
  Country United States (USA)
  Street 255 State Street
  City 85354 Boston, MA
  Tel +1-857-246-8998
    Address record changed: 2018-01-23
     
Basic data Employees n. a.
  Currency USD
  Annual sales 25,275,000 (revenues, consolidated (2017) 2017-12-31)
  Profit -17,647,000 (2017-12-31)
  Cash 37,878,000 (2017-12-31)
     
    * Document for �About Section�: Pieris Pharmaceuticals, Inc.. (8/10/17). "Press Release: Pieris Pharmaceuticals Appoints Allan Reine, M.D., as Chief Financial Officer". Boston, MA.
     
   
Record changed: 2019-06-09

Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

More documents for Pieris (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

SilverSky LifeSciences DxPx Conference 2019 Düsseldorf Medica 600x60px




» top